Anzeige
Mehr »
Login
Donnerstag, 03.04.2025 Börsentäglich über 12.000 News von 693 internationalen Medien
Warum Almonty Industries zum Schlüsselplayer für NATO-Staaten wird
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 603035 | ISIN: US0042251084 | Ticker-Symbol: DR6
Tradegate
31.03.25
21:13 Uhr
15,340 Euro
+0,025
+0,16 %
1-Jahres-Chart
ACADIA PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
ACADIA PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
14,50014,67015:36
14,54014,68515:35

Aktuelle News zur ACADIA PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
14.03.Acadia Pharmaceuticals issues new employee stock awards2
04.03.Acadia's Q4 Earnings Miss, Nuplazid & Daybue Drive Revenue Growth (Revised)1
03.03.Acadia Pharmaceuticals Inc.: Acadia Pharmaceuticals and Saniona Announce Initial Positive Results from ACP-711 (formerly SAN711) Phase 1 Study251Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) and Saniona (OMX: SANION) today announced the successful completion of the two originally planned cohorts in their Phase 1 multiple-ascending-dose MAD study...
► Artikel lesen
27.02.ACADIA PHARMACEUTICALS INC - 10-K, Annual Report-
27.02.Demystifying ACADIA Pharmaceuticals: Insights From 5 Analyst Reviews1
27.02.Acadia's Q4 Earnings Miss, Nuplazid & Daybue Drive Revenue Growth1
26.02.Acadia Pharma GAAP EPS of $0.86 beats by $0.63, revenue of $259.6M misses by $13.44M5
ACADIA PHARMACEUTICALS Aktie jetzt für 0€ handeln
26.02.ACADIA PHARMACEUTICALS INC - 8-K, Current Report-
26.02.ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) CFO Mark C. Schneyer Sells 773 Shares2
15.01.Acadia submits MAA to EMA for Rett syndrome therapy2
14.01.ACADIA Pharmaceuticals (NASDAQ:ACAD) Shares Down 6.9% - Should You Sell?1
14.01.Acadia Pharma Submits MAA To EU Agency For Approval Of Trofinetide In Rett Syndrome-
14.01.Acadia Pharmaceuticals Inc.: Acadia Pharmaceuticals Submits Marketing Authorization Application to the European Medicines Agency for Trofinetide for the Treatment of Rett Syndrome248-- Filing marks company's first Marketing Authorization Application in Europe Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the company has submitted a Marketing Authorization...
► Artikel lesen
02.01.Why ACADIA Pharmaceuticals Inc. (ACAD) Is Skyrocketing4
31.12.24Acadia Pharmaceuticals, FTAI Aviation And Other Big Stocks Moving Higher On Tuesday5
31.12.24Acadia Pharmaceuticals will replace Independent Bank Group in S&P SmallCap 6006
30.12.24S&P Dow Jones Indices: Acadia Pharmaceuticals Set to Join S&P SmallCap 600201NEW YORK, Dec. 30, 2024 /PRNewswire/ -- Acadia Pharmaceuticals Inc. (NASD: ACAD) will replace Independent Bank Group Inc. (NASD: IBTX) in the S&P SmallCap 600...
► Artikel lesen
11.12.24ACADIA PHARMACEUTICALS INC - 8-K, Current Report-
09.12.24Acadia nabs Lexicon, Bristol Myers Squibb veteran as new commercial lead26
27.11.24Acadia signs agreement with Saniona to commercialise SAN7112
Seite:  Weiter >>
37 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2